###begin article-title 0
Association study of functional genetic variants of innate immunity related genes in celiac disease
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Recent evidence suggest that the innate immune system is implicated in the early events of celiac disease (CD) pathogenesis. In this work for the first time we have assessed the relevance of different proinflammatory mediators typically related to innate immunity in CD predisposition.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 195 238 195 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 242 248 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 104 109 <span type="species:ncbi:9606">child</span>
We performed a familial study in which 105 celiac families characterized by the presence of an affected child with CD were genotyped for functional polymorphisms located at regulatory regions of IL-1alpha, IL-1beta, IL-1RN, IL-18, RANTES and MCP-1 genes. Familial data was analysed with a transmission disequilibrium test (TDT) that revealed no statistically significant differences in the transmission pattern of the different genetic markers considered.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 21 55 21 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18</italic>
###xml 61 67 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 185 192 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
The TDT analysis for IL-1alpha, IL-1beta, IL-1RN, IL-18, and MCP-1 genes genetic variants did not reveal biased transmission to the affected offspring. Only a borderline association of RANTES promoter genetic variants with CD predisposition was observed.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 55 98 55 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 102 108 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
Our results suggest that the analysed polymorphisms of IL-1alpha, IL-1beta, IL-1RN, IL-18, RANTES and MCP-1 genes do not seem to play a major role in CD genetic predisposition in our population.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
###xml 548 556 <span type="species:ncbi:9606">patients</span>
Celiac disease (CD) is an autoimmune disorder of the small intestine in which dietary gluten ingestion leads to a chronic inflammatory status of the mucosa [1]. There is strong evidence for a genetic component for CD, with the HLA genes being the strongest genetic locus associated with CD predisposition known to date. About 95% of CD patients are carriers of the DQ2 molecule, encoded by DQA1*05/DQB1*02 alleles, compared to ~10% of healthy control subjects. Furthermore, the DQ8 molecule (DQA1*0301/DQB1*0302 is also found more frequently in CD patients although to a lesser extent [2]. Finally, a role for genes located outside the HLA region has been suggested since the overall contribution of HLA genes to CD genetic predisposition is no more than 40% [1].
###end p 11
###begin p 12
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
T CD4+ lymphocytes are key elements in the induction and progression of CD pathogenesis. Certain gluten peptides bound to DQ2 or DQ8 molecules cause proliferation and production of proinflammatory cytokines by lamina propria CD4 +T cells [3]. Besides this activation of adaptive immune response, recent evidences suggest that there is an implication of the innate immunity in the initial phases of CD [4]. In this regard, some gluten peptides have been demonstrated to drive a danger signal that leads to an activation of the innate immune system [5,6] and additionally it is thought that bacteria may play a role in CD [7]. In fact, CD patients show an up-regulation in the expression of pro-inflammatory cytokines typically related to the innate immune response, such us IL1, IL-18 and chemokines [6,8-10].
###end p 12
###begin p 13
###xml 312 314 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 534 536 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 537 539 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 678 680 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 687 694 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1RN </italic>
###xml 790 792 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 918 920 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
The IL1 gene cluster located in the chromosomal region 2q12-22 codifies for three proteins: IL-1alpha, IL-1beta and IL-1 receptor agonist (IL-1RN), of which the two first are strong inducers of inflammation while IL-1RN is an effective antagonist binding to the IL-1 receptor without activating the target cell [11]. These genes are polymorphic bearing well-characterized single nucleotide polymorphisms (SNPs). Polymorphisms in IL-1alpha at position -889 C/T (rs1800587) and IL-1beta at position -511 C/T (rs1143627) were described [12,13]. Furthermore, recent findings showed that the -511 C/T IL-1beta genetic variant is related to differences in IL-1beta protein secretion [14]. The IL-1RN gene contains within its second intron a variable number of an 86-bp tandem repeats (rs380092) [15], showing the allele 2 (IL-1RN*2; two repeats) an increased frequency in a variety of autoimmune and inflammatory disorders [16].
###end p 13
###begin p 14
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
Another important member of the proinflammatory IL-1 family is IL-18, which is thought to be a key regulator of cytokine expression [17]. Furthermore, a role for IL-18 in the induction of an anti-gluten inflammatory response has been suggested [10,18,19]. It is thought that IL-18 gene variation in the promoter region regulates the expression of this cytokine [20]. Interestingly, in the IL-18 promoter region two SNPs -607 A/C (rs1946518) and -137 G/C (rs187238) were described, which are supposed to alter the IL-18 promoter activity [21].
###end p 14
###begin p 15
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 422 428 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
Moreover, raised levels of chemokines such us RANTES (regulated upon activation, normal T-cells expressed and secreted) and monocyte chemoatractant protein-1 (MCP-1) have been observed in the primary immune response to gluten in CD patients [6,8]. Interestingly, genetic variants within regulatory regions that can affect trancription and protein production levels, RANTES -403 G/A (rs2107538) and -28 G/C (rs2280788) and MCP-1 -2518 G/A (rs1024611) SNPs, were described [22-24].
###end p 15
###begin p 16
###xml 107 150 107 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 154 160 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
Taking into consideration these findings, in this work we aimed to investigate the possible implication of IL-1alpha, IL-1beta, IL-1RN, IL-18, RANTES and MCP-1 functional polymorphisms in CD susceptibility.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 18
###begin p 19
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 113 118 <span type="species:ncbi:9606">child</span>
###xml 138 150 <span type="species:ncbi:9606">participants</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
###xml 546 551 <span type="species:ncbi:9606">women</span>
###xml 561 564 <span type="species:ncbi:9606">men</span>
###xml 751 759 <span type="species:ncbi:9606">patients</span>
In the present work we have analysed a panel of 105 celiac families characterised by the presence of an affected child with CD. The study participants were recruited at "Hospital Materno-Infantil" and "Hospital Clinico Universitario", Granda, (Spain) and were of Spanish Caucasian origin. All patients were diagnosed following the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria for CD [25]. Their age at study was 7.1 +/- 3.9 years and the mean age for disease diagnosis was 2.7 +/- 2.72. A 60% were women and 40 % men, showing an anthropometry at diagnosis (weight and height) of P 3-100 percentile. The mean age of gluten introduction was 6.4 +/- 1.5 months. Typical symptoms were observed in 72.2 % of patients and 27.8 % showed atypical symptoms. All family members were genotyped in DRB1 and DQB1. DQA1 typing was deduced from DQB1 and DRB1 typing on the basis of the strong linkage disequilibrium among HLA class II alleles.
###end p 19
###begin title 20
Genotyping
###end title 20
###begin p 21
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1RN </italic>
###xml 140 147 140 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 913 918 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTE</italic>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
DNA from patients and controls was obtained from peripheral blood using standard methods. For all of the considered SNPs, except IL-1RN and RANTES -403, samples were genotyped using a Taqman 5' allelic discrimination assay. Table 1 shows the Taqman MGB probes sequences used for each polymorphism provided by the Custom-Taqman-SNP-Genotyping-Assay (Applied Biosystems, Foster City, CA, USA). PCR reaction was carried in a total reaction volume of 5 mul with the following amplification protocol: denaturation at 92degreesC for 10 min, followed by 50 cycles of denaturation at 92degreesC for 15 sec and annealing and extension at 58degreesC for 1 min. Post-PCR, the genotype of each sample was attributed automatically by measuring the allelic specific fluorescence on the ABI PRIM 7900 Sequence Detection Systems using the SDS 2.2.1 software for allelic discrimination (Applied Biosystems, Foster City, CA, USA). RANTES -403 genotyping was performed using a TaqMan SNP-Genotyping-Assay (part number: C__15874407_10, Applied Biosystems, Foster City, CA, USA).
###end p 21
###begin p 22
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1RN </italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
The IL-1RN polymorphism was genotyped by PCR as previously described [26]. Briefly, we used a froward primer 5'- CTC AGC AAC ACCT CCT AT and reverse primer 5'- TCC TGG TCT GCA GGT AA, two amplify five possible alleles with different PCR fragment size: 410 bp (allele 1: 4 repeats), 240 bp (allele 2: two repeats), 325 bp (allele 3: 3 repeats), 500 bp (allele 4: 5 repeats), and 595 bp (allele 5: 6 repeats).
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
We used the UNPHASED software created for TDT and case-control analysis [27]. We performed a Transmission Disequilibrium Test (TDT), which assesses allele transmission rates in simplex families and tests for deviation from expected 50% transmission. For the haplotype analysis, pair-wise linkage disequilibrium measures were investigated and haplotypes constructed using the expectation-maximization (EM) algorithm implemented in UNPHASED software. The power of the study to detect an effect of a polymorphism in disease susceptibility was estimated using the Quanto v 0.5 software (Department of Preventive Medicine University of Southern California, California, USA) [28].
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
IL1 gene cluster
###end title 26
###begin p 27
###xml 29 39 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945; </italic>
###xml 45 49 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1</italic>
###xml 63 70 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1RN </italic>
###xml 107 108 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 374 376 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 437 438 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 456 463 445 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1RN </italic>
###xml 645 647 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 300 308 <span type="species:ncbi:9606">children</span>
The transmission pattern for IL-1alpha -889, IL-1beta -511 and IL-1RN VNTR polymorphisms is shown in table 2. When transmission of these genetic variants was analysed, none of the alleles showed statistically significant skewing. IL-1alpha -889 T allele was slightly more transmitted to the affected children (58% transmission for allele T vs 47% for allele C), however the p value failed to reach statistically significant level (Table 2). With regard to IL-1RN we observed that alleles IL-1RN*1 and IL-1RN*2 were the most frequent in our population (71.6% and 26.8% respectively), accordingly with previously studies in Caucasian populations [26].
###end p 27
###begin title 28
IL18 gene
###end title 28
###begin p 29
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-18 </italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
The TDT analysis for -607 A/C and -137 G/C IL-18 promoter genetic variants did not reveal biased transmission of any of the alleles to the affected offspring (Table 2).
###end p 29
###begin p 30
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-18 </italic>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-18 </italic>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
The haplotype estimation for the -607 A/C and -137 IL-18 promoter variants revealed complete linkage disequilibrium between the two variants (D' = 1). We observed three out of the four possible haplotypic combinations in CD families (Table 3). The transmission pattern of IL-18 promoter haplotypes did not show any statistically significant skewing (Table 3).
###end p 30
###begin title 31
MCP-1 and RANTES
###end title 31
###begin p 32
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 653 655 653 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 666 668 666 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 696 697 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 954 961 954 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 1001 1002 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
After analyzing the MCP-1 -2518 G/A alleles transmission we observed that none of the alleles was preferentially transmitted from heterozygous parents to the affected offspring (Table 2). Regarding to the RANTES promoter genetic variants the mutant alleles -403 A and -28 G showed an overall allele frequency similar to that expected for Caucasian populations (84.1% and 96.5% respectively in our population) [29,30]. The transmission of both -403G/A and -28 C/G SNPs showed a slightly deviation from the 50% expected transmission pattern (Table 2). Alleles -403 G and -28 C were more transmitted to the affected offspring with borderline significance (P = 0.04 and P = 0.06 respectively) (Table 2). In addition, we estimated haplotypes for both genetic variants. Three out of the four haplotypic combinations were observed, being the -403G/-28C and -403A/-28C haplotypes the most common in CD families. No significant distorted transmission pattern for RANTES promoter haplotypes was observed (Table 3).
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 413 414 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 543 544 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
CD is considered a model for autoimmune disorders since many of the components that generate the altered immune response to gluten have been well characterized [1]. However, there are some relevant events of CD pathogenesis that remain unclear, for instance the stimuli that drives the high IFNgamma levels in the small intestine of CD patients and why only one out of 20-30 DQ2-positive individuals develops CD [3]. An explanation for these questions might be provided from recent studies that point out a role for the innate immunity in CD [4]. This finding supports a novel focus of research in CD molecular and genetic basis, opening a new field for the functional search of CD candidate genes.
###end p 34
###begin p 35
###xml 67 110 67 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 114 120 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 249 251 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 252 254 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 304 338 297 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18</italic>
###xml 344 350 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 487 494 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
In this work, for the first time we have assessed the relevance of IL-1alpha, IL-1beta, IL-1RN, IL-18, RANTES and MCP-1 genes in CD predisposition. All these genes have been previously associated with susceptibility to several autoimmune disorders [31-40]. However, we failed to detect an association of IL-1alpha, IL-1beta, IL-1RN, IL-18, and MCP-1 genes with CD predisposition using a TDT analysis in our cohort of 105 simplex CD families. Only a borderline significant association of RANTES promoter genetic variants with CD predisposition was observed.
###end p 35
###begin p 36
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 151 158 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 523 530 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 725 732 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 838 845 838 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 917 924 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
Several studies have focused on the role of RANTES -403G/A and -28 G/C promoter polymorphisms in susceptibility to different autoimmune disorders. The RANTES -403A allele has been associated with susceptibility to multiple sclerosis (MS) and polymialgia rheumatica [41,42]. On the other hand, the RANTES -28G allele was observed to be a genetic risk for clinical complications such us diabetic neprhopathy, early onset of MS, lower levels of C3 in SLE, and higher incidence of central nervous system lupus [37,38,41]. Both RANTES -403A and -28G alleles were associated with higher RANTES expression levels [22,23]. However, considering the multiple testing of the 6 different genes of our study, the association observed for RANTES promoter variants in our population can not be considered as being significant. Therefore, our results of RANTES suggest that further studies should be performed to clarify the role of RANTES in CD and autoimmune diseases in general.
###end p 36
###begin p 37
###xml 638 645 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
###xml 837 844 837 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
Using a familial approach we eliminate the risk of population stratification derived from case-control association studies. In addition, we estimated that our study design would have considerable power to detect the effect of a polymorphism with moderate to high risk for CD. Assuming an additive model, a minor allele frequency of 0.30 (corresponding to a median value of the majority of markers considered) and RR of 1.8 we would reach 81% power to detect an association in our population. Nevertheless, under a dominant model the power drops to 49% and considering a lower disease allele frequency, for instance 0.16 as is the case of RANTES -28, our study power would decrease to a 64% for a RR of 1.8, and increases to 82% when we assume a RR of 2.0. For this reason, the low level of significance that our TDT analysis reached for RANTES promoter genetic variants might well reflect a true positive, and therefore needs further confirmation using a larger group of CD families.
###end p 37
###begin p 38
###xml 93 136 93 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL1-&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 140 146 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 588 590 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 912 914 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 902 910 <span type="species:ncbi:9606">patients</span>
Taking into account our findings, it is suggested that the analysed genetic polymorphisms of IL-1alpha, IL1-beta, IL-1RN, IL-18, RANTES and MCP-1 genes seem not to play a major role in CD susceptibility in our population. It might be possible that the release of these cytokines and chemokines observed in CD patients could be derived from the activity of other innate immunity related pro-inflammatory mediators with higher influence in disease pathogenesis. In this regard, it is known that in CD the cytokine expression pattern in response to gluten is strongly dominated by IFNgamma [43]. Of note, in a recent work we assessed the influence of a functional dinucleotide polymorphism of IFNgamma gene in CD predisposition. An association of a higher IFNgamma producer allele with CD was observed, supporting a possible explanation for the high levels of INFgamma observed in intestinal mucosa of CD patients [44].
###end p 38
###begin p 39
###xml 262 264 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 265 267 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 655 657 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 658 660 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
Other proinflammatory mediators related with innate immunity such as, TNF-alpha and IL-12, has been analysed with respect to CD susceptibility. In accordance with our findings no evidence of association was found between IL-12 and CD in two independent studies [45,46]. Regarding TNF-alpha it has been difficult to dissect the relevance of this genetic marker in CD since it maps within HLA clas III region and it shows linkage disequilibrium with CD disease predisposing DQ2 alleles. In fact controversial results have been obtained, and there is no consensus about an independent or due to linkage disequilibrium role of TNF-alpha in CD susceptibility [47,48].
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 25 68 25 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL1-&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 72 78 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
###xml 187 194 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RANTES </italic>
Our results suggest that IL-1alpha, IL1-beta, IL-1RN, IL-18, RANTES and MCP-1 genetic variants do not play a major role in CD genetic predisposition, although the suggestive evidence for RANTES deserves further investigation. Furthermore, we consider the innate response an intriguing focus of research and it should be of interest to investigate the role of other cytokines up-regulated in the early events of CD.
###end p 41
###begin title 42
Competing interests
###end title 42
###begin p 43
The author(s) declare that they have no competing interests.
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
B.R., carried out the genotyping and statistical analysis and drafted the manuscript.
###end p 45
###begin p 46
A.Z., participated in the genotyping and helped in the use of the ABI PRIM 7900 Sequence Detection Systems and SDS 2.2.1 software.
###end p 46
###begin p 47
M.A. L-N., collected the samples and revised the manuscript.
###end p 47
###begin p 48
J.M., participated in the manuscript design and coordination and helped to draft the manuscript
###end p 48
###begin p 49
B.K., reviewed the statistical analysis and helped to draft the manuscript.
###end p 49
###begin p 50
All authors read and approved the final manuscript.
###end p 50
###begin title 51
Pre-publication history
###end title 51
###begin p 52
The pre-publication history for this paper can be accessed here:
###end p 52
###begin p 53

###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
This work was supported by grant SAF03-460 from Plan Nacional de I+D (CICYT), and in part by Consejeria de Educacion, Junta de Andalucia, grupo CTS-180.
###end p 55
###begin p 56
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B.K</bold>
B.K. is supported by the Dutch Diabetes Research Foundation, The Netherlands Organisation for Health Research and Development (ZonMW) and The Juvenile Diabetes Research Foundation International (JDRF) (2001.10.004).
###end p 56
###begin article-title 57
Coeliac disease: dissecting a complex inflammatory disorder
###end article-title 57
###begin article-title 58
HLA in coeliac disease: Unravelling the complex genetics of a complex disorder
###end article-title 58
###begin article-title 59
Coeliac disease
###end article-title 59
###begin article-title 60
Innate immunity and coeliac disease
###end article-title 60
###begin article-title 61
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease
###end article-title 61
###begin article-title 62
Activation of macrophages by gliadin fragments: isolation and characterization of active peptide
###end article-title 62
###begin article-title 63
Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease
###end article-title 63
###begin article-title 64
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Increased proinflammatory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge
###end article-title 64
###begin article-title 65
Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia?
###end article-title 65
###begin article-title 66
Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease
###end article-title 66
###begin article-title 67
The balance between IL-1 and IL-1Ra in disease
###end article-title 67
###begin article-title 68
###xml 40 45 <span type="species:ncbi:9606">human</span>
Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)
###end article-title 68
###begin article-title 69
A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism
###end article-title 69
###begin article-title 70
Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein
###end article-title 70
###begin article-title 71
###xml 16 21 <span type="species:ncbi:9606">human</span>
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
###end article-title 71
###begin article-title 72
Influence of interleukin-1 receptor antagonist gene polymorphism on disease
###end article-title 72
###begin article-title 73
Interleukin-18
###end article-title 73
###begin article-title 74
Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance
###end article-title 74
###begin article-title 75
###xml 58 66 <span type="species:ncbi:9606">children</span>
Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease
###end article-title 75
###begin article-title 76
Regulation of IL-18 (IFN-gamma-inducing factor) gene expression
###end article-title 76
###begin article-title 77
###xml 37 42 <span type="species:ncbi:9606">human</span>
Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation
###end article-title 77
###begin article-title 78
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
###end article-title 78
###begin article-title 79
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study
###end article-title 79
###begin article-title 80
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression
###end article-title 80
###begin article-title 81
Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition
###end article-title 81
###begin article-title 82
Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England
###end article-title 82
###begin article-title 83
Methods and software for association tests of uncertain haplotypes in case-parent trios
###end article-title 83
###begin article-title 84
Candidate gene association analysis for a quantitative trait, using parent-offspring trios
###end article-title 84
###begin article-title 85
###xml 43 48 <span type="species:ncbi:9606">human</span>
A rare polymorphism at position -28 in the human RANTES promoter
###end article-title 85
###begin article-title 86
###xml 39 44 <span type="species:ncbi:9606">human</span>
A polymorphism at position -403 in the human RANTES promoter
###end article-title 86
###begin article-title 87
Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States
###end article-title 87
###begin article-title 88
The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis
###end article-title 88
###begin article-title 89
Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity
###end article-title 89
###begin article-title 90
Relationship of polymorphisms of the Interleukin-1 gene cluster to occurrence and severity of rheumatoid arthritis
###end article-title 90
###begin article-title 91
Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease
###end article-title 91
###begin article-title 92
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults
###end article-title 92
###begin article-title 93
RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects
###end article-title 93
###begin article-title 94
###xml 125 133 <span type="species:ncbi:9606">children</span>
Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus
###end article-title 94
###begin article-title 95
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis
###end article-title 95
###begin article-title 96
The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE
###end article-title 96
###begin article-title 97
RANTES: a genetic risk marker for multiple sclerosis
###end article-title 97
###begin article-title 98
RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis
###end article-title 98
###begin article-title 99
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease
###end article-title 99
###begin article-title 100
A functional variant of IFNgamma gene is associated with coeliac disease
###end article-title 100
###begin article-title 101
The IL12B gene does not confer susceptibility to coeliac disease
###end article-title 101
###begin article-title 102
IL12B and IRF1 gene polymorphisms and susceptibility to celiac disease
###end article-title 102
###begin article-title 103
Celiac disease and TNF promoter polymorphisms
###end article-title 103
###begin article-title 104
Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population
###end article-title 104
###begin title 105
Figures and Tables
###end title 105
###begin p 106
Taqman probes used for cytokine genotyping
###end p 106
###begin p 107
###xml 54 97 54 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-1&#945;, IL-1&#946;, IL-1RN, IL-18, RANTES </italic>
###xml 101 107 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1 </italic>
Allelic frequencies and percentage of transmission of IL-1alpha, IL-1beta, IL-1RN, IL-18, RANTES and MCP-1 genetic variants in CD families.
###end p 107
###begin p 108
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T </italic>
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NT </italic>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">%T </italic>
T = transmitted, NT = not transmitted %T = percentage transmitted
###end p 108
###begin p 109
Transmission pattern of haplotypes inferred for IL-18 and RANTES promoter genetic variant in CD families
###end p 109

